More
    Guided Solutions - Connecting Talent With Innovation/div>

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based company plans to offer 4.25 million shares of common stock...

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    GS MedTech Funding Tracker – Terumo, Tempus AI & more

    Capital is flowing across many corners of MedTech - with landmark acquisitions, major growth financings, and early bets on emerging technologies. This week’s investor...

    Peytant reports positive tracheobronchial covered stent results

    Peytant Solutions announced positive pre-clinical outcomes for its AMStent tracheobronchial covered stent system. Dr. Roy Joseph Cho of the University of Minnesota presented the outcomes...

    Vaxxas raises $58.4M for needle-free vaccine delivery tech

    Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Peytant reports positive tracheobronchial covered stent results

    Peytant Solutions announced positive pre-clinical outcomes for its AMStent tracheobronchial covered stent system. Dr. Roy Joseph Cho of the University of Minnesota presented the outcomes...

    Stimvia reports positive outcomes with neuromodulation for Parkinson’s

    Stimvia announced it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) technology. The Czech Republic-based company delivers peroneal eTNM through its...

    Simpson Interventions reports first patient treated with Acolyte catheter

    Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system. The Acolyte study, a pivotal investigational device...

    Fractyl reports positive 2-year Revita results, prices $20m offering

    Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

    Innovation

    Regulatory Approvals

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    GS MedTech Funding Tracker – Terumo, Tempus AI & more

    Capital is flowing across many corners of MedTech - with landmark acquisitions, major growth financings, and early bets on emerging technologies. This week’s investor...

    Peytant reports positive tracheobronchial covered stent results

    Peytant Solutions announced positive pre-clinical outcomes for its AMStent tracheobronchial covered stent system. Dr. Roy Joseph Cho of the University of Minnesota presented the outcomes...

    Vaxxas raises $58.4M for needle-free vaccine delivery tech

    Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32...

    M&A

    Archives

    Latest articles